alignment healthcare inc - ALHC
ALHC
Close Chg Chg %
21.15 0.60 2.84%
Closed Market
21.75
+0.60 (2.84%)
Volume: 2.11M
Last Updated:
Feb 6, 2026, 4:00 PM EDT
Company Overview: alignment healthcare inc - ALHC
ALHC Key Data
| Open $21.08 | Day Range 20.96 - 21.77 |
| 52 Week Range 11.63 - 23.87 | Market Cap $4.27B |
| Shares Outstanding 200.09M | Public Float 174.17M |
| Beta 1.16 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.11 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.94M |
ALHC Performance
| 1 Week | -3.46% | ||
| 1 Month | 4.67% | ||
| 3 Months | 33.19% | ||
| 1 Year | 47.56% | ||
| 5 Years | N/A |
ALHC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
13
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | Average Target Price | 24.917 | |
| Number of Ratings | 13 | Current Quarters Estimate | 0.012 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 0.096 | |
| Last Quarter’s Earnings | -0.162 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.102 | Next Fiscal Year Estimate | 0.366 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 9 | 9 | 10 | 8 |
| Mean Estimate | 0.01 | 0.11 | 0.10 | 0.37 |
| High Estimates | 0.05 | 0.20 | 0.15 | 0.48 |
| Low Estimate | -0.04 | 0.03 | 0.01 | 0.25 |
| Coefficient of Variance | 220.59 | 47.05 | 39.21 | 27.19 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 10 | 10 | 10 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 2 | 2 | 2 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Alignment Healthcare Inc - ALHC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Alignment Healthcare Inc - ALHC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Sep 18, 2025 | Joseph S. Konowiecki Director | 1,110,973 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $16.24 per share | 18,042,201.52 |
| Apr 4, 2025 | Christopher J. Joyce Chief Legal and Admin. Officer | 415,022 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $18.47 per share | 7,665,456.34 |
| Mar 24, 2025 | Hyong J. Kim Chief Medical Officer | 509,367 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $17.22 per share | 8,771,299.74 |
| Mar 14, 2025 | Hakan Kardes Chief Experience Officer | 678,137 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.74 per share | 10,673,876.38 |
| Mar 14, 2025 | Hakan Kardes Chief Experience Officer | 678,206 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.42 per share | 10,457,936.52 |
| Mar 14, 2025 | Thomas Freeman Chief Financial Officer | 1,402,862 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.74 per share | 22,081,047.88 |
| Mar 14, 2025 | Thomas Freeman Chief Financial Officer | 1,403,070 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.42 per share | 21,635,339.40 |
| Mar 14, 2025 | Robert L. Scavo Chief Information Officer | 668,106 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.74 per share | 10,515,988.44 |
| Mar 14, 2025 | Robert L. Scavo Chief Information Officer | 668,181 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.42 per share | 10,303,351.02 |
| Mar 14, 2025 | Dawn C. Maroney President | 2,276,732 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.74 per share | 35,835,761.68 |
| Mar 14, 2025 | Dawn C. Maroney President | 2,277,117 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.42 per share | 35,113,144.14 |
| Mar 14, 2025 | John E. Kao Chief Executive Officer; Director | 4,680,542 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.74 per share | 73,671,731.08 |
| Mar 14, 2025 | John E. Kao Chief Executive Officer; Director | 4,681,292 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.42 per share | 72,185,522.64 |
| Mar 14, 2025 | John E. Kao Chief Executive Officer; Director | 2,093,100 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.72 per share | 32,903,532.00 |
| Mar 14, 2025 | John E. Kao Chief Executive Officer; Director | 2,093,200 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.36 per share | 32,151,552.00 |
| Mar 7, 2025 | Hyong J. Kim Chief Medical Officer | 515,502 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.72 per share | 8,103,691.44 |
| Mar 7, 2025 | Hyong J. Kim Chief Medical Officer | 507,876 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.53 per share | 7,887,314.28 |
| Mar 7, 2025 | Thomas Freeman Chief Financial Officer | 1,417,554 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.53 per share | 22,014,613.62 |
| Mar 7, 2025 | Christopher J. Joyce Chief Legal and Admin. Officer | 386,974 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.53 per share | 6,009,706.22 |
| Mar 7, 2025 | Christopher J. Joyce Chief Legal and Admin. Officer | 397,845 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $15.58 per share | 6,198,425.10 |